Dallas, TX -- (SBWIRE) -- 09/11/2014 -- Global Non-small Cell Lung Cancer Market 2014-2018 is a new research report available at ReportsnReports.com Non-small cell lung cancer occurs when normal cells grow and multiply without control after undergoing a cell transformation. Lung cancer is the leading cause of cancer deaths worldwide, and the incidence of lung cancer is increasing significantly. Lung cancer is the common cause of mortality and morbidity not only in developed countries but also in developing countries. One of the most common types of lung cancer is non-small cell lung cancer. It grows and spreads quite slowly. Smoking is considered as a major cause of lung cancer, although lung cancer also occurs in non-smokers. There are three main types of non-small cell lung cancer: squamous cell (epidermoid) carcinoma, adenocarcinoma, and large cell (undifferentiated) carcinoma. Some of the common symptoms associated with non-small cell lung cancer are chest pain, a cough that does not go away, coughing up blood, fatigue, loss of appetite, losing weight without trying, shortness of breath, and wheezing.
Analysts forecast the Global Non-small Cell Lung Cancer market to grow at a CAGR of 3.62 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Non-small Cell Lung Cancer market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through various therapies adopted for the treatment of non-small cell lung cancer, including
Biologics
Small Molecules
The Global Non-small Cell Lung Cancer Market 2014-2018 has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Non-small Cell Lung Cancer market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
- Americas
- APAC
- EMEA
Key Vendors
-AstraZeneca
-Celgene
-Eli Lilly
-F. Hoffmann-La Roche
-Pfizer
Other Prominent Vendors
-Aetna
-Boehringer Ingelheim
-Celldex
-Eisai
-GlaxoSmithKline
-IMClone
-Merck Serono
-Novartis
-Qiagen
-OncoGenex
-OSI Pharmaceuticals
-Pierre Fabre
-Sanofi
-Synta
Order a copy of this report at (Prices start at US$2500 for a single user PDF) http://www.reportsnreports.com/purchase.aspx?name=297740.
Market Driver
-High Unmet Needs
-For a full, detailed list, view our report
Market Challenge
-High Cost of Therapy
-For a full, detailed list, view our report
Market Trend
-Availability of Personalized Medicine
-For a full, detailed list, view our report
Key Questions Answered in this Report
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?